Duobrii - (0.01%/0.045%; Topical Lotion)

Generic Name	Halobetasol Propionate and Tazarotene	Innovator	Bausch health
Dosage	0.01%/0.045%; Topical Lotion	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	Less Than 5
Final Approvals	None	Generic Launches	None
Indication	Indicated for the topical treatment of plaque psoriasis in adults
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******* - ******	*** \ *********	*** **, ****	**** ** **	****	***** **** ****
*** (****)	** \ **	*** *, ****	*** ** **	********* ********	****** **** ********

Chronology Of Events